ReinaHaqueReina Haque, PhD, MPH34.14383190000000-118.14096620000000168Haque, ReinaH0000-0001-8563-3330Dr. Haque's research interests include pharmacoepidemiology and cancer risk, detection and screening for cancer, broad areas of cancer epidemiology including molecular markers of fatal prostate cancer and breast cancer prognosis, and survivorship among cancer patients.Research Scientist IIIprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:orcidIdORCID idvivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson100 South Los Robles AvenuePasadena91101CADivision of ResearchDepartment of Research and EvaluationKaiser Permanente Northern CaliforniaKaiser Permanente Southern CaliforniaDeborahYoungDeborah Rohm Young, PhD, MBA34.14383190000000-118.14096620000000100Young, Deborah0000-0002-8335-7851Director, Division of Behavioral ResearchKarenColemanKaren J. Coleman, PhD, MS34.14383190000000-118.14096620000000124Coleman, Karen0000-0002-2052-0885Research Scientist IIIDariosGetahunDarios Getahun, MD, PhD, MPH34.14383190000000-118.14096620000000138Getahun, Darios0000-0003-3610-8841Research Scientist IIAlanGoAlan S. Go, MD37.80931810000000-122.26769880000000148Go, Alan0000-0001-9109-0811Associate Director, Cardiovascular and Metabolic ConditionsLawrenceKushiLawrence H. Kushi, ScD37.80931810000000-122.26769880000000155Kushi, Lawrence0000-0001-9136-1175Director of Scientific Policy, Division of ResearchLaurelHabelLaurel A. Habel, PhD37.80931810000000-122.26769880000000166Habel, Laurel0000-0002-7230-587XResearch Scientist III1194selected publications5.424580.0127049312research areas2.199140.023492821coauthor of199.25829.334760similar toChunChaoChun R. Chao, PhD, MS34.14383190000000-118.1409662000000063Chao, Chun0000-0002-6072-4954Research Scientist IIIJeffSlezakJeff Slezak, MS34.14383190000000-118.1409662000000070Slezak, Jeff0000-0002-6108-9198Research Scientist ILeiQianLei Qian, PhD34.14383190000000-118.1409662000000076Qian, LeiResearch Scientist IAnnetteAdamsAnnette L. Adams, PhD, MPH34.14383190000000-118.1409662000000078Adams, Annette0000-0001-7338-4808Research Scientist IBetteCaanBette J. Caan, DrPH37.80931810000000-122.2676988000000080Caan, Bette0000-0002-5803-310XResearch Scientist IIIStephenEedenStephen K. Van Den Eeden, PhD37.80931810000000-122.2676988000000097Eeden, Stephen0000-0002-5599-8387Research Scientist IIIMarilynKwanMarilyn L. Kwan, PhD37.80931810000000-122.2676988000000099Kwan, Marilyn0000-0001-8863-3950Research Scientist IIIAuthorship 1000210Authorship 101469Authorship 102421Authorship 103595Authorship 104326Authorship 106214Authorship 107244Authorship 107615Authorship 107636Authorship 107931Authorship 108113Authorship 108265Authorship 109264Authorship 110581Authorship 111512Authorship 113957Authorship 114315Authorship 115164Authorship 115576Authorship 115835Authorship 116112Authorship 117191Authorship 119263Authorship 119811Authorship 120682Authorship 122676Authorship 123551Authorship 125922Authorship 126151Authorship 126424Authorship 1285810Authorship 129163Authorship 129241Authorship 52871Authorship 54199Authorship 54759Authorship 55031Authorship 55272Authorship 56401Authorship 60846Authorship 61743Authorship 64735Authorship 64898Authorship 65282Authorship 67166Authorship 70071Authorship 71565Authorship 72154Authorship 72481Authorship 73186Authorship 74493Authorship 74603Authorship 74733Authorship 79154Authorship 79669Authorship 79964Authorship 80258Authorship 80845Authorship 80991Authorship 82533Authorship 84409Authorship 85374Authorship 94041Authorship 9774516093295von Ehrenstein OS, Mazumder DN, Yuan Y, Samanta S, Balmes J, Sil A, Ghosh N, Hira-Smith M, Haque R, Purushothamam R, Lahiri S, Das S, Smith AHAmerican journal of epidemiologyDecrements in lung function related to arsenic in drinking water in West Bengal, India. Am J Epidemiol. 2005 Sep 15; 162(6):533-41.Am J Epidemiol2005-08-10T00:00:002005Decrements in lung function related to arsenic in drinking water in West Bengal, India.12606883Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, Mitra S, Santra A, Lahiri S, Das S, De BK, Smith AHEpidemiology (Cambridge, Mass.)Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology. 2003 Mar; 14(2):174-82.Epidemiology2003-03-01T00:00:002003Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India.17393300Aiello EJ, Buist DS, Wagner EH, Tuzzio L, Greene SM, Lamerato LE, Field TS, Herrinton LJ, Haque R, Hart G, Bischoff KJ, Geiger AMBreast cancer research and treatmentDiffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network. Breast Cancer Res Treat. 2008 Feb; 107(3):397-403.Breast Cancer Res Treat2007-03-28T00:00:002007Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network.17767135Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LAModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncClinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007 Nov; 20(11):1149-55.Mod Pathol2007-08-31T00:00:002007Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients.16503981Haque R, Contreras R, McNicoll MP, Eckberg EC, Petitti DBBMC ear, nose, and throat disordersSurgical margins and survival after head and neck cancer surgery. BMC Ear Nose Throat Disord. 2006 Feb 17; 6:2.BMC Ear Nose Throat Disord2006-02-17T00:00:002006Surgical margins and survival after head and neck cancer surgery.18840839Jacobsen SJ, Cheetham TC, Haque R, Shi JM, Loo RKJAMAAssociation between 5-alpha reductase inhibition and risk of hip fracture. JAMA. 2008 Oct 08; 300(14):1660-4.JAMA2008-10-08T00:00:002008Association between 5-alpha reductase inhibition and risk of hip fracture.15238285Mitra SR, Mazumder DN, Basu A, Block G, Haque R, Samanta S, Ghosh N, Smith MM, von Ehrenstein OS, Smith AHEnvironmental health perspectivesNutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect. 2004 Jul; 112(10):1104-9.Environ Health Perspect2004-07-01T00:00:002004Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India.15797628Haque R, Enger SM, Chen W, Petitti DBCancer lettersBreast cancer risk in a large cohort of female antidepressant medication users. Cancer Lett. 2005 Apr 18; 221(1):61-5.Cancer Lett2005-04-18T00:00:002005Breast cancer risk in a large cohort of female antidepressant medication users.17559138Haque R, Quinn VP, Habel LA, Enger SM, Sternfeld B, Van Den Eeden SK, Sadler M, Chiu V, Caan BCancerCorrelates of screening sigmoidoscopy use among men in a large nonprofit health plan. Cancer. 2007 Jul 15; 110(2):275-81.Cancer2007-07-15T00:00:002007Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan.17971519Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, Haque R, Orav EJ, Seeger JD, Sadler MC, Quesenberry CP, Sternfeld B, Jacobsen SJ, Whitmer RA, Caan BJCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyStatin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.Cancer Epidemiol Biomarkers Prev2007-10-30T00:00:002007Statin use and risk of prostate cancer in the California Men's Health Study cohort.21878589Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VPCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyLong-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev. 2011 Oct; 20(10):2120-6.Cancer Epidemiol Biomarkers Prev2011-08-30T00:00:002011Long-term safety of radiotherapy and breast cancer laterality in older survivors.22435746Quinn VP, Jacobsen SJ, Slezak JM, Van Den Eeden SK, Caan B, Sternfeld B, Haque RThe American journal of managed carePreventive care and health behaviors among overweight/obese men in HMOs. Am J Manag Care. 2012 Jan; 18(1):25-32.Am J Manag Care2012-01-01T00:00:002012Preventive care and health behaviors among overweight/obese men in HMOs.22491230Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SWJournal of the National Cancer InstituteTen-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21.J Natl Cancer Inst2012-04-05T00:00:002012Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS.19634923Flick ED, Habel LA, Chan KA, Haque R, Quinn VP, Van Den Eeden SK, Sternfeld B, Orav EJ, Seeger JD, Quesenberry CP, Caan BJDrugsStatin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57.Drugs2009-07-30T00:00:002009Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study.19922614Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CPBreast cancer research : BCRDeclining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.Breast Cancer Res2009-11-18T00:00:002009Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.19950406Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LAThe American journal of surgical pathologyRelationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.Am J Surg Pathol2009-12-01T00:00:002009Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.20090948Cheng I, Witte JS, Jacobsen SJ, Haque R, Quinn VP, Quesenberry CP, Caan BJ, Van Den Eeden SKPloS oneProstatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One. 2010 Jan 15; 5(1):e8736.PLoS One2010-01-15T00:00:002010Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study.20661834Chao C, Haque R, Caan BJ, Poon KY, Tseng HF, Quinn VPNutrition and cancerRed wine consumption not associated with reduced risk of colorectal cancer. Nutr Cancer. 2010; 62(6):849-55.Nutr Cancer2010-01-01T00:00:002010Red wine consumption not associated with reduced risk of colorectal cancer.23421436Van Den Eeden SK, Ferrara A, Shan J, Jacobsen SJ, Quinn VP, Haque R, Quesenberry CPBMC urologyImpact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol. 2013 Feb 20; 13:12.BMC Urol2013-02-20T00:00:002013Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.23624751Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LABreast cancer research and treatmentRisk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60.Breast Cancer Res Treat2013-04-27T00:00:002013Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ.23647433Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JL, Thwin SS, Silliman RA, Field TSJournal of the American Geriatrics SocietyFracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc. 2013 Jun; 61(6):888-95.J Am Geriatr Soc2013-05-06T00:00:002013Fracture risk in older, long-term survivors of early-stage breast cancer.24638009Potosky AL, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Jiang M, Tsai HT, Luta G, Keating NL, Smith MR, Van Den Eeden SKJournal of clinical oncology : official journal of the American Society of Clinical OncologyEffectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol. 2014 May 01; 32(13):1324-30.J Clin Oncol2014-03-17T00:00:002014Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.26602222Chlebowski RT, Haque R, Hedlin H, Col N, Paskett E, Manson JE, Kubo JT, Johnson KC, Wactawski-Wende J, Pan K, Anderson GBreast cancer research and treatmentBenefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity. Breast Cancer Res Treat. 2015 Dec; 154(3):609-16.Breast Cancer Res Treat2015-11-24T00:00:002015Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.26631176Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, Avila C, Kleinman K, Habel LA, Fletcher SW, Kwan MLJournal of the National Cancer InstituteTamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3).J Natl Cancer Inst2015-12-01T00:00:002015Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.27002508Kwan ML, Shi JM, Habel LA, Song J, Chung JW, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque RBreast cancer research and treatmentEffectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.Breast Cancer Res Treat2016-03-22T00:00:002016Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.24441675Chlebowski RT, Kim J, Haque RCancer prevention research (Philadelphia, Pa.)Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res (Phila). 2014 Apr; 7(4):378-87.Cancer Prev Res (Phila)2014-01-17T00:00:002014Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.25757699Chlebowski RT, Schottinger JE, Shi J, Chung J, Haque RCancerAromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors. Cancer. 2015 Jul 01; 121(13):2147-55.Cancer2015-03-10T00:00:002015Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.25769058Haque R, Shi J, Schottinger JE, Ahmed SA, Chung J, Avila C, Lee VS, Cheetham TC, Habel LA, Fletcher SW, Kwan MLMedical careA hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care. 2015 Apr; 53(4):380-5.Med Care2015-04-01T00:00:002015A hybrid approach to identify subsequent breast cancer using pathology and automated health information data.26355571Chao C, Xu L, Silverberg MJ, MartÃnez-Maza O, Chen LH, Castor B, Abrams DI, Zha HD, Haque R, Said JAIDS (London, England)Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS. 2015 Sep 24; 29(15):1943-51.AIDS2015-09-24T00:00:002015Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.26668177Chlebowski RT, Anderson GL, Sarto GE, Haque R, Runowicz CD, Aragaki AK, Thomson CA, Howard BV, Wactawski-Wende J, Chen C, Rohan TE, Simon MS, Reed SD, Manson JEJournal of the National Cancer InstituteContinuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. J Natl Cancer Inst. 2016 Mar; 108(3).J Natl Cancer Inst2015-12-14T00:00:002015Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.27084777Fu AZ, Tsai HT, Haque R, Ulcickas Yood M, Van Den Eeden SK, Cassidy-Bushrow AE, Zhou Y, Keating NL, Smith MR, Aaronson DS, Potosky ALWorld journal of urologyUse of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619.World J Urol2016-04-15T00:00:002016Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.18618281McEligot AJ, Im T, Dillman RO, West JG, Salem R, Haque R, Anton-Culver HCancer causes & control : CCCAbstracting height and weight from medical records, and breast cancer pathologic factors. Cancer Causes Control. 2008 Dec; 19(10):1217-26.Cancer Causes Control2008-07-10T00:00:002008Abstracting height and weight from medical records, and breast cancer pathologic factors.16222165Mazumder DN, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, Sil A, Balmes JR, Haque R, Hira-Smith MM, Smith AHEpidemiology (Cambridge, Mass.)Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology. 2005 Nov; 16(6):760-5.Epidemiology2005-11-01T00:00:002005Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water.16287897Haque R, Chiu V, Mehta KR, Geiger AMJournal of the National Cancer Institute. MonographsAn automated data algorithm to distinguish screening and diagnostic colorectal cancer endoscopy exams. J Natl Cancer Inst Monogr. 2005; (35):116-8.J Natl Cancer Inst Monogr2005-01-01T00:00:002005An automated data algorithm to distinguish screening and diagnostic colorectal cancer endoscopy exams.16332366Chung JS, Haque R, Guha Mazumder DN, Moore LE, Ghosh N, Samanta S, Mitra S, Hira-Smith MM, von Ehrenstein O, Basu A, Liaw J, Smith AHEnvironmental researchBlood concentrations of methionine, selenium, beta-carotene, and other micronutrients in a case-control study of arsenic-induced skin lesions in West Bengal, India. Environ Res. 2006 Jun; 101(2):230-7.Environ Res2005-12-05T00:00:002005Blood concentrations of methionine, selenium, beta-carotene, and other micronutrients in a case-control study of arsenic-induced skin lesions in West Bengal, India.17149142von Ehrenstein OS, Poddar S, Yuan Y, Mazumder DG, Eskenazi B, Basu A, Hira-Smith M, Ghosh N, Lahiri S, Haque R, Ghosh A, Kalman D, Das S, Smith AHEpidemiology (Cambridge, Mass.)Children's intellectual function in relation to arsenic exposure. Epidemiology. 2007 Jan; 18(1):44-51.Epidemiology2007-01-01T00:00:002007Children's intellectual function in relation to arsenic exposure.19796017Smith JF, Caan BJ, Sternfeld B, Haque R, Quesenberry CP, Quinn VP, Shan J, Walsh TJ, Lue TF, Jacobsen SJ, Van den Eeden SKThe journal of sexual medicineRacial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med. 2009 Dec; 6(12):3433-9.J Sex Med2009-09-30T00:00:002009Racial disparities in erectile dysfunction among participants in the California Men's Health Study.19840393Ahmed AT, Quinn VP, Caan B, Sternfeld B, Haque R, Van Den Eeden SKBMC public healthGenerational status and duration of residence predict diabetes prevalence among Latinos: the California Men's Health Study. BMC Public Health. 2009 Oct 19; 9:392.BMC Public Health2009-10-19T00:00:002009Generational status and duration of residence predict diabetes prevalence among Latinos: the California Men's Health Study.19843686Bosco JL, Lash TL, Prout MN, Buist DS, Geiger AM, Haque R, Wei F, Silliman RACancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyBreast cancer recurrence in older women five to ten years after diagnosis. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):2979-83.Cancer Epidemiol Biomarkers Prev2009-10-20T00:00:002009Breast cancer recurrence in older women five to ten years after diagnosis.19895183Haque R, Van Den Eeden SK, Jacobsen SJ, Caan B, Avila CC, Slezak J, Sternfeld B, Loo RK, Quinn VPThe American journal of managed careCorrelates of prostate-specific antigen testing in a large multiethnic cohort. Am J Manag Care. 2009 Nov; 15(11):793-9.Am J Manag Care2009-11-01T00:00:002009Correlates of prostate-specific antigen testing in a large multiethnic cohort.20469955Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LAThe American journal of managed careTreatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60.Am J Manag Care2010-05-01T00:00:002010Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans.22798182Kwan ML, Haque R, Lee VS, Joanie Chung WL, Avila CC, Clancy HA, Quinn VP, Kushi LHCancer causes & control : CCCValidation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.Cancer Causes Control2012-07-14T00:00:002012Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries.22989461Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, Bernstein L, Enger SM, Press MFCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyImpact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1848-55.Cancer Epidemiol Biomarkers Prev2012-09-18T00:00:002012Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades.23292083Wallner LP, Wang R, Jacobsen SJ, Haque RCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyAndrogen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):313-6.Cancer Epidemiol Biomarkers Prev2013-01-04T00:00:002013Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies.23342281Haque R, Ahmed SA, Fisher A, Avila CC, Shi J, Guo A, Craig Cheetham T, Schottinger JECancer medicineEffectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer. Cancer Med. 2012 Dec; 1(3):318-27.Cancer Med2012-09-26T00:00:002012Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer.19433691Nekhlyudov L, Habel LA, Achacoso NS, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SWJournal of clinical oncology : official journal of the American Society of Clinical OncologyAdherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 01; 27(19):3211-6.J Clin Oncol2009-05-11T00:00:002009Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery.19457638Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, Prout MN, Yood MU, Haque R, Wei F, Lash TLJournal of clinical epidemiologyA most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010 Jan; 63(1):64-74.J Clin Epidemiol2009-05-19T00:00:002009A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.19521962Chao C, Haque R, Van Den Eeden SK, Caan BJ, Poon KY, Quinn VPInternational journal of cancerRed wine consumption and risk of prostate cancer: the California men's health study. Int J Cancer. 2010 Jan 01; 126(1):171-9.Int J Cancer2010-01-01T00:00:002010Red wine consumption and risk of prostate cancer: the California men's health study.21334642Gleason JM, Slezak JM, Jung H, Reynolds K, Van den Eeden SK, Haque R, Quinn VP, Loo RK, Jacobsen SJThe Journal of urologyRegular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol. 2011 Apr; 185(4):1388-93.J Urol2011-02-22T00:00:002011Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction.22100004Van Den Eeden SK, Shan J, Jacobsen SJ, Aaronsen D, Haque R, Quinn VP, Quesenberry CPThe Journal of urologyEvaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol. 2012 Jan; 187(1):185-9.J Urol2011-11-17T00:00:002011Evaluating racial/ethnic disparities in lower urinary tract symptoms in men.22634367Irwin MR, Olmstead RE, Ganz PA, Haque RBrain, behavior, and immunitySleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun. 2013 Mar; 30 Suppl:S58-67.Brain Behav Immun2012-05-24T00:00:002012Sleep disturbance, inflammation and depression risk in cancer survivors.22711707Chao C, Silverberg MJ, MartÃnez-Maza O, Chi M, Abrams DI, Haque R, Zha HD, McGuire M, Xu L, Said JClinical cancer research : an official journal of the American Association for Cancer ResearchEpstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma. Clin Cancer Res. 2012 Sep 01; 18(17):4702-12.Clin Cancer Res2012-06-18T00:00:002012Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.22764638Ghai NR, Jacobsen SJ, Van Den Eeden SK, Ahmed AT, Haque R, Rhoads GG, Quinn VPEthnicity & diseaseA comparison of lifestyle and behavioral cardiovascular disease risk factors between Asian Indian and White non-Hispanic men. Ethn Dis. 2012; 22(2):168-74.Ethn Dis2012-01-01T00:00:002012A comparison of lifestyle and behavioral cardiovascular disease risk factors between Asian Indian and White non-Hispanic men.25524243Tsai HT, Keating NL, Van Den Eeden SK, Haque R, Cassidy-Bushrow AE, Ulcickas Yood M, Smith MR, Potosky ALThe Journal of urologyRisk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer. J Urol. 2015 Jun; 193(6):1956-62.J Urol2014-12-15T00:00:002014Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.25589617Chao C, Silverberg MJ, Xu L, Chen LH, Castor B, MartÃnez-Maza O, Abrams DI, Zha HD, Haque R, Said JClinical cancer research : an official journal of the American Association for Cancer ResearchA comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection. Clin Cancer Res. 2015 Mar 15; 21(6):1429-37.Clin Cancer Res2015-01-14T00:00:002015A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.25664181Soffer D, Shi J, Chung J, Schottinger JE, Wallner LP, Chlebowski RT, Lentz SE, Haque RBMJ open diabetes research & careMetformin and breast and gynecological cancer risk among women with diabetes. BMJ Open Diabetes Res Care. 2015; 3(1):e000049.BMJ Open Diabetes Res Care2015-01-24T00:00:002015Metformin and breast and gynecological cancer risk among women with diabetes.26059650Collins LC, Achacoso N, Haque R, Nekhlyudov L, Quesenberry CP, Schnitt SJ, Habel LA, Fletcher SWAnnals of surgical oncologyRisk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S502-8.Ann Surg Oncol2015-06-10T00:00:002015Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.27100398Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac A, Chlebowski RTJAMA oncologyCardiovascular Disease After Aromatase Inhibitor Use. JAMA Oncol. 2016 Dec 01; 2(12):1590-1597.JAMA Oncol2016-12-01T00:00:002016Cardiovascular Disease After Aromatase Inhibitor Use.26475981Adams AL, Shi JM, Reynolds K, Haque R, Cheetham TC, Kawatkar AA, Fithian DC, Jacobsen SJAnnals of epidemiologyStatins and hip fracture risk in men: a population-based case-control study. Ann Epidemiol. 2015 Nov; 25(11):844-8.Ann Epidemiol2015-08-29T00:00:002015Statins and hip fracture risk in men: a population-based case-control study.24512167Haque R, Prout M, Geiger AM, Kamineni A, Thwin SS, Avila C, Silliman RA, Quinn V, Yood MUThe American journal of managed careComorbidities and cardiovascular disease risk in older breast cancer survivors. Am J Manag Care. 2014; 20(1):86-92.Am J Manag Care2014-01-01T00:00:002014Comorbidities and cardiovascular disease risk in older breast cancer survivors.24939060Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AMBreast cancer research and treatmentIncident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat. 2014 Jul; 146(2):401-9.Breast Cancer Res Treat2014-06-18T00:00:002014Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.Authorship 13409328007467Fu AZ, Tsai HT, Haque R, Yood MU, Cassidy-Bushrow AE, Van Den Eeden SK, Keating NL, Smith MR, Zhou Y, Aaronson DS, Potosky ALThe Journal of urologyMortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 06; 197(6):1448-1454.J Urol2016-12-19T00:00:002016Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.Authorship 135061027900490Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJBreast cancer research and treatmentDiscordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample. Breast Cancer Res Treat. 2017 01; 161(2):375-384.Breast Cancer Res Treat2016-11-29T00:00:002016Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample.Authorship 13954128259737Haque R, Shi J, Chung J, Xu X, Avila C, Campbell C, Ahmed SA, Chen L, Schottinger JEJournal of the American Pharmacists Association : JAPhAMedication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO. J Am Pharm Assoc (2003). 2017 May - Jun; 57(3):303-310.e2.J Am Pharm Assoc (2003)2017-03-01T00:00:002017Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO.2014-03-31NIHHAQUE, REINA2010-04-15ABC: Antidepressants and Breast Cancer PharmacoepidemiologyR01CA1367432021-06-30NIHIRWIN, MICHAEL R2016-07-01Sleep Disturbance, Inflammation, and Cellular Aging in Breast Cancer SurvivorsR01CA207130Principal InvestigatorCo-Principal Investigator3Assistant Investigator / Research Scientist I2Investigator / Research Scientist II1Senior Investigator / Research Scientist IIIAuthorship 16941828610450Chao C, Silverberg MJ, Chen LH, Xu L, MartÃnez-Maza O, Abrams DI, Zha HD, Haque R, Said JLeukemia & lymphomaNovel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. Leuk Lymphoma. 2018 02; 59(2):321-329.Leuk Lymphoma2017-06-13T00:00:002017Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma.23661613Weinmann S, Van Den Eeden SK, Haque R, Chen C, Richert-Boe K, Schwartzman J, Gao L, Berry DL, Kallakury BV, Alumkal JJThe ProstateImmunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study. Prostate. 2013 Sep; 73(13):1371-7.Prostate2013-05-09T00:00:002013Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study.25091359Haque R, Van Den Eeden SK, Wallner LP, Richert-Boe K, Kallakury B, Wang R, Weinmann SObesity research & clinical practiceAssociation of body mass index and prostate cancer mortality. Obes Res Clin Pract. 2014 Jul-Aug; 8(4):e374-81.Obes Res Clin Pract2013-08-06T00:00:002013Association of body mass index and prostate cancer mortality.25625043Feigelson HS, Carroll NM, Weinmann S, Haque R, Yu CL, Butler MG, Waitzfelder B, Wrenn MG, Capra A, McGlynn EA, Habel LASpringerPlusTreatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans. Springerplus. 2015; 4:24.Springerplus2015-01-17T00:00:002015Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans.D013629Chemicals & Drugs21600.951941TamoxifenAuthorship 17563129017178Haque R, UlcickasYood M, Xu X, Cassidy-Bushrow AE, Tsai HT, Keating NL, Van Den Eeden SK, Potosky ALBritish journal of cancerCardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. Br J Cancer. 2017 Oct 10; 117(8):1233-1240.Br J Cancer2017-08-24T00:00:002017Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.D011471Disorders402970.797721Prostatic NeoplasmsD047072Chemicals & Drugs13340.964131Aromatase InhibitorsD00007311633780.903137Cancer SurvivorsAuthorship 188136Authorship 19285129959604Bradley MC, Zhou Y, Freedman AN, Yood MU, Quesenbery CP, Haque R, Van Den Eeden SK, Cassidy-Bushrow AE, Aaronson D, Potosky ALCancer causes & control : CCCRisk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer. Cancer Causes Control. 2018 Aug; 29(8):785-791.Cancer Causes Control2018-06-29T00:00:002018Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer.30405302Haque R, Xu X, Shi J, Kwan ML, Chlebowski RTEthnicity & diseaseBreast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women. Ethn Dis. 2018; 28(4):565-574.Ethn Dis2018-10-18T00:00:002018Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women.Authorship 19576530659431Xu X, Chlebowski RT, Shi J, Barac A, Haque RBreast cancer research and treatmentAromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. Breast Cancer Res Treat. 2019 Apr; 174(3):785-794.Breast Cancer Res Treat2019-01-18T00:00:002019Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.Authorship 209141Authorship 229524Authorship 239313Authorship 237251Authorship 216504Authorship 246784Authorship 22252132096056Alvarado M, Tiller GE, Chung J, Haque RJournal of community geneticsPrevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan. J Community Genet. 2020 Jul; 11(3):359-366.J Community Genet2020-02-24T00:00:002020Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan.33539175Haque R, Chen LJCO clinical cancer informaticsSARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors. JCO Clin Cancer Inform. 2021 02; 5:168-175.JCO Clin Cancer Inform2021-02-01T00:00:002021SARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors.34002959Cooper RM, Chung J, Hogan T, Haque RThe American journal of managed careInfluence of health care systems on mortality in adult patients with cancer. Am J Manag Care. 2021 05; 27(5):182-185.Am J Manag Care2021-05-01T00:00:002021Influence of health care systems on mortality in adult patients with cancer.32145911Haque R, Skates SJ, Armstrong MA, Lentz SE, Anderson M, Jiang W, Alvarado MM, Chillemi G, Shaw SF, Kushi LH, Powell CBGynecologic oncologyFeasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations. Gynecol Oncol. 2020 05; 157(2):521-528.Gynecol Oncol2020-03-04T00:00:002020Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations.33012551Lentz SE, Powell CB, Haque R, Armstrong MA, Anderson M, Liu Y, Jiang W, Chillemi G, Shaw S, Alvarado MM, Kushi LH, Skates SJGynecologic oncologyDevelopment of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations. Gynecol Oncol. 2020 12; 159(3):804-810.Gynecol Oncol2020-10-01T00:00:002020Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations.33035108Haque R, Hsu JW, Avila C, Olmstead R, Carroll JE, Irwin MRJournal of women's health (2002)Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors. J Womens Health (Larchmt). 2020 Oct 09.J Womens Health (Larchmt)2020-10-09T00:00:002020Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors.33783687Cooper RM, Chung J, Hogan T, Haque RCancer causes & control : CCCPatterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California. Cancer Causes Control. 2021 Jun; 32(6):609-616.Cancer Causes Control2021-03-30T00:00:002021Patterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California.2021-08-31NIHHAQUE, REINA2018-05-01Is depression associated with prostate cancer progression?R03CA2194472024-06-30NIHHAQUE, REINA2020-07-01Risk prediction of breast cancer treatment-related cardiotoxicity to guide clinical decision makingR01HL154319Principal InvestigatorPrincipal InvestigatorAuthorship 26795134586512Haque R, Chlebowski RT, Chen LBreast cancer research and treatmentSleep medication use and risk of fractures in breast cancer survivors. Breast Cancer Res Treat. 2021 Dec; 190(3):541-548.Breast Cancer Res Treat2021-09-29T00:00:002021Sleep medication use and risk of fractures in breast cancer survivors.Health Systems ScienceAuthorship 282488Authorship 284345Authorship 286753Authorship 28718535803481Irwin MR, Olmstead R, Kruse J, Breen EC, Haque RBrain, behavior, and immunityAssociation of interleukin-8 and risk of incident and recurrent depression in long-term breast cancer survivors. Brain Behav Immun. 2022 Jul 05; 105:131-138.Brain Behav Immun2022-07-05T00:00:002022Association of interleukin-8 and risk of incident and recurrent depression in long-term breast cancer survivors.35816026Vasbinder A, Zaslavsky O, Heckbert SR, Thompson H, Cheng RK, Saquib N, Wallace R, Haque R, Paskett ED, Reding KWCancer nursingAssociations of Health-Related Quality of Life and Sleep Disturbance With Cardiovascular Disease Risk in Postmenopausal Breast Cancer Survivors. Cancer Nurs. 2022 Jul 02.Cancer Nurs2022-07-02T00:00:002022Associations of Health-Related Quality of Life and Sleep Disturbance With Cardiovascular Disease Risk in Postmenopausal Breast Cancer Survivors.35670038Carroll JE, Olmstead R, Haque R, Irwin MRCancerAccelerated mononuclear cell telomere attrition in breast cancer survivors with depression history: A 2-year longitudinal cohort study. Cancer. 2022 Aug 15; 128(16):3109-3119.Cancer2022-06-07T00:00:002022Accelerated mononuclear cell telomere attrition in breast cancer survivors with depression history: A 2-year longitudinal cohort study.35861620Wallner LP, Chen LH, Hogan TA, Brasfield FM, Haque RCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyThe influence of medical comorbidities on survival disparities in a multi-ethnic group of patients with de novo metastatic breast cancer. Cancer Epidemiol Biomarkers Prev. 2022 Jul 21.Cancer Epidemiol Biomarkers Prev2022-07-21T00:00:002022The influence of medical comorbidities on survival disparities in a multi-ethnic group of patients with de novo metastatic breast cancer.Kaiser Permanente Bernard J. Tyson School of MedicineAuthorship 294075Authorship 300776Authorship 295872Authorship 297094Authorship 29800136083407Haque R, Reading S, Irwin MR, Chen LH, Slezak JCancer causes & control : CCCAntidepressant medication use and prostate cancer recurrence in men with depressive disorders. Cancer Causes Control. 2022 Nov; 33(11):1363-1372.Cancer Causes Control2022-09-09T00:00:002022Antidepressant medication use and prostate cancer recurrence in men with depressive disorders.36228942Rosenthal A, Reddy S, Cooper R, Chung J, Zhang J, Haque R, Kim CJournal of the American Academy of DermatologyDisparities in melanoma-specific mortality by race/ethnicity, socioeconomic status, and health care systems. J Am Acad Dermatol. 2023 Mar; 88(3):560-567.J Am Acad Dermatol2022-10-11T00:00:002022Disparities in melanoma-specific mortality by race/ethnicity, socioeconomic status, and health care systems.36261688Hoffman TL, Kershberg H, Goff J, Holmquist KJ, Haque R, Alvarado MFamilial cancerNext-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO. Fam Cancer. 2022 Oct 20.Fam Cancer2022-10-20T00:00:002022Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.36449286Kwan ML, Haque R, Young-Wolff KC, Lee VS, Roh JM, Ergas IJ, Wang Z, Cannavale KL, Ambrosone CB, Loo RK, Aaronson DS, Quesenberry CP, Kushi LH, Tang LJAMA network openSmoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study. JAMA Netw Open. 2022 11 01; 5(11):e2244430.JAMA Netw Open2022-11-01T00:00:002022Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.36394875Chen LH, Irwin MR, Olmstead R, Haque RJAMA network openAssociation of Physical Activity With Risk of Mortality Among Breast Cancer Survivors. JAMA Netw Open. 2022 11 01; 5(11):e2242660.JAMA Netw Open2022-11-01T00:00:002022Association of Physical Activity With Risk of Mortality Among Breast Cancer Survivors.Authorship 30565636911890Swope M, Alem AC, Russo SC, Gin NE, Chevez SG, Haque RThe Permanente journalDeveloping a Community-Oriented and Place-Based Strategy to Improve COVID-19 Vaccine Accessibility. Perm J. 2023 03 15; 27(1):103-112.Perm J2023-03-13T00:00:002023Developing a Community-Oriented and Place-Based Strategy to Improve COVID-19 Vaccine Accessibility.Authorship 31032937265450Patel J, Attaluri V, Basam M, Ryoo J, Wu D, Mukherjee A, Chung J, Cooper RM, Haque RThe American surgeonInvestigating Mortality Disparities Among Insured Patients With Colon Cancer Treated in an Integrated Health care System and Other Private Settings. Am Surg. 2023 Jun 02; 31348221146950.Am Surg2023-06-02T00:00:002023Investigating Mortality Disparities Among Insured Patients With Colon Cancer Treated in an Integrated Health care System and Other Private Settings.Authorship 313765Authorship 314445Authorship 31671137925391Mukherjee A, Gu Z, Chen LH, Potosky AL, Haque RJournal of cancer research and clinical oncologyAssociation of metabolic syndrome conditions with risk of second primary uterine cancer in breast cancer survivors. J Cancer Res Clin Oncol. 2023 Nov 04.J Cancer Res Clin Oncol2023-11-04T00:00:002023Association of metabolic syndrome conditions with risk of second primary uterine cancer in breast cancer survivors.37605715Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RTBreast cancer (Dove Medical Press)Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan. Breast Cancer (Dove Med Press). 2023; 15:637-645.Breast Cancer (Dove Med Press)2023-08-16T00:00:002023Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan.37771179Cooper RM, Chao C, Mukherjee A, Zhuang Z, Haque RCancer control : journal of the Moffitt Cancer CenterInfluence of Comorbidity Burden, Socioeconomic Status, and Race and Ethnicity on Survival Disparities in Patients With Cancer. Cancer Control. 2023 Jan-Dec; 30:10732748231204474.Cancer Control2023-01-01T00:00:002023Influence of Comorbidity Burden, Socioeconomic Status, and Race and Ethnicity on Survival Disparities in Patients With Cancer.true1Research Scientist IIIResearch Scientist IIItrue1Research Scientist IResearch Scientist Itrue1Research Scientist IResearch Scientist Itrue1Research Scientist IResearch Scientist Itrue1Director, Division of Behavioral ResearchDirector, Division of Behavioral Researchtrue1Research Scientist IIIResearch Scientist IIItrue1Research Scientist IIResearch Scientist IItrue1Research Scientist IIIResearch Scientist IIItrue1Research Scientist IIIResearch Scientist IIItrue1Research Scientist IIIResearch Scientist IIItrue1Research Scientist IIIResearch Scientist IIItrue1Associate Director, Cardiovascular and Metabolic ConditionsAssociate Director, Cardiovascular and Metabolic Conditionstrue1Director of Scientific Policy, Division of ResearchDirector of Scientific Policy, Division of Researchtrue1Research Scientist IIIResearch Scientist III2ProfessorProfessorD001943Disorders8310050.549473Breast Neoplasms